Literature DB >> 19397311

Crystal structures of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole: ligand-induced structural response through alpha-helical repositioning.

Sean C Gay1, Ling Sun, Keiko Maekawa, James R Halpert, C David Stout.   

Abstract

Two different ligand occupancy structures of cytochrome P450 2B4 (CYP2B4) in complex with 1-biphenyl-4-methyl-1H-imidazole (1-PBI) have been determined by X-ray crystallography. 1-PBI belongs to a series of tight binding, imidazole-based CYP2B4 inhibitors. 1-PBI binding to CYP2B4 yields a type II spectrum with a K(s) value of 0.23 microM and inhibits enzyme activity with an IC(50) value of 0.035 microM. Previous CYP2B4 structures have shown a large degree of structural movement in response to ligand size. With two phenyl rings, 1-PBI is larger than 1-(4-chlorophenyl)imidazole (1-CPI) and 4-(4-chlorophenyl)imidazole (4-CPI) but smaller than bifonazole, which is branched and contains three phenyl rings. The CYP2B4-1-PBI complex is a structural intermediate to the closed CPI and the open bifonazole structures. The B/C-loop reorganizes itself to include two short partial helices while closing one side of the active site. The F-G-helix cassette pivots over the I-helix in direct response to the size of the ligand in the active site. A cluster of Phe residues at the fulcrum of this pivot point allows for dramatic repositioning of the cassette with only a relatively small amount of secondary structure rearrangement. Comparisons of ligand-bound CYP2B4 structures reveal trends in plastic region mobility that could allow for predictions of their position in future structures based on ligand shape and size.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397311      PMCID: PMC2764533          DOI: 10.1021/bi9003765

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Crystal structure of a thermophilic cytochrome P450 from the archaeon Sulfolobus solfataricus.

Authors:  J K Yano; L S Koo; D J Schuller; H Li; P R Ortiz de Montellano; T L Poulos
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 2.  Crystallization of cytochromes P450 and substrate-enzyme interactions.

Authors:  Huiying Li; Thomas L Poulos
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

3.  Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction.

Authors:  Yonghong Zhao; Mark A White; B K Muralidhara; Ling Sun; James R Halpert; C David Stout
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

4.  Conformational flexibility of mammalian cytochrome P450 2B4 in binding imidazole inhibitors with different ring chemistry and side chains. Solution thermodynamics and molecular modeling.

Authors:  B K Muralidhara; Surendra Negi; Christopher C Chin; Werner Braun; James R Halpert
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

5.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences.

Authors:  O Gotoh
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

6.  Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.

Authors:  A Bridges; L Gruenke; Y T Chang; I A Vakser; G Loew; L Waskell
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Structural and thermodynamic consequences of 1-(4-chlorophenyl)imidazole binding to cytochrome P450 2B4.

Authors:  Yonghong Zhao; Ling Sun; B K Muralidhara; Santosh Kumar; Mark A White; C David Stout; James R Halpert
Journal:  Biochemistry       Date:  2007-09-22       Impact factor: 3.162

8.  The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.

Authors:  Jason K Yano; Michael R Wester; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

9.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  30 in total

1.  Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity.

Authors:  Sean C Gay; Haoming Zhang; P Ross Wilderman; Arthur G Roberts; Tong Liu; Sheng Li; Hsia-Lien Lin; Qinghai Zhang; Virgil L Woods; C David Stout; Paul F Hollenberg; James R Halpert
Journal:  Biochemistry       Date:  2011-05-13       Impact factor: 3.162

2.  Multiple ligand docking by Glide: implications for virtual second-site screening.

Authors:  Márton Vass; Ákos Tarcsay; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

Review 3.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

4.  Functional importance of a peripheral pocket in mammalian cytochrome P450 2B enzymes.

Authors:  Hyun-Hee Jang; Jingbao Liu; Ga-Young Lee; James R Halpert; P Ross Wilderman
Journal:  Arch Biochem Biophys       Date:  2015-08-28       Impact factor: 4.013

Review 5.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

Review 6.  Clinical and molecular pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

7.  NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation.

Authors:  Arthur G Roberts; Sara E A Sjögren; Nadezda Fomina; Kathy T Vu; Adah Almutairi; James R Halpert
Journal:  Biochemistry       Date:  2011-03-04       Impact factor: 3.162

8.  Double electron-electron resonance shows cytochrome P450cam undergoes a conformational change in solution upon binding substrate.

Authors:  Stefan Stoll; Young-Tae Lee; Mo Zhang; Richard F Wilson; R David Britt; David B Goodin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

Review 9.  Structural diversity of eukaryotic membrane cytochrome p450s.

Authors:  Eric F Johnson; C David Stout
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

10.  Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.

Authors:  Manish B Shah; P Ross Wilderman; Jaime Pascual; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Biochemistry       Date:  2012-09-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.